11/13
08:11 am
lucd
Lucid Diagnostics (NASDAQ:LUCD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $3.00 price target on the stock.
Medium
Report
Lucid Diagnostics (NASDAQ:LUCD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $3.00 price target on the stock.
11/13
05:59 am
lucd
Rating for LUCD
Medium
Report
Rating for LUCD
11/13
05:59 am
lucd
Rating for LUCD
Medium
Report
Rating for LUCD
10/6
06:04 am
lucd
Rating for LUCD
Low
Report
Rating for LUCD
9/10
12:32 pm
lucd
Rating for LUCD
Low
Report
Rating for LUCD